Moderna Inc (MRNA)
100.61
-1.39
(-1.36%)
USD |
NASDAQ |
Apr 19, 15:24
Moderna Price to Book Value: 2.780 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 2.819 |
| April 17, 2024 | 2.859 |
| April 16, 2024 | 2.868 |
| April 15, 2024 | 2.870 |
| April 12, 2024 | 2.906 |
| April 11, 2024 | 2.957 |
| April 10, 2024 | 2.961 |
| April 09, 2024 | 3.084 |
| April 08, 2024 | 2.904 |
| April 05, 2024 | 2.843 |
| April 04, 2024 | 2.826 |
| April 03, 2024 | 2.797 |
| April 02, 2024 | 2.863 |
| April 01, 2024 | 2.918 |
| March 28, 2024 | 2.945 |
| March 27, 2024 | 3.056 |
| March 26, 2024 | 2.968 |
| March 25, 2024 | 3.050 |
| March 22, 2024 | 2.914 |
| March 21, 2024 | 2.877 |
| March 20, 2024 | 2.849 |
| March 19, 2024 | 2.905 |
| March 18, 2024 | 2.881 |
| March 15, 2024 | 2.870 |
| March 14, 2024 | 2.859 |
| Date | Value |
|---|---|
| March 13, 2024 | 2.944 |
| March 12, 2024 | 3.052 |
| March 11, 2024 | 3.095 |
| March 08, 2024 | 2.847 |
| March 07, 2024 | 2.749 |
| March 06, 2024 | 2.706 |
| March 05, 2024 | 2.635 |
| March 04, 2024 | 2.648 |
| March 01, 2024 | 2.622 |
| February 29, 2024 | 2.544 |
| February 28, 2024 | 2.688 |
| February 27, 2024 | 2.653 |
| February 26, 2024 | 2.593 |
| February 23, 2024 | 2.660 |
| February 22, 2024 | 2.742 |
| February 21, 2024 | 2.416 |
| February 20, 2024 | 2.399 |
| February 16, 2024 | 2.437 |
| February 15, 2024 | 2.513 |
| February 14, 2024 | 2.370 |
| February 13, 2024 | 2.354 |
| February 12, 2024 | 2.454 |
| February 09, 2024 | 2.410 |
| February 08, 2024 | 2.582 |
| February 07, 2024 | 2.738 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.970
Minimum
Nov 09 2023
29.17
Maximum
Aug 09 2021
7.961
Average
4.375
Median
Feb 28 2022
Price to Book Value Benchmarks
| Eli Lilly and Co | 64.17 |
| Merck & Co Inc | 8.481 |
| Pfizer Inc | 1.644 |
| Johnson & Johnson | 5.168 |
| Novavax Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 5.769 |
| Price | 100.61 |
| Earnings Yield | -12.33% |
| Market Cap | 38.52B |